SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-038130
Filing Date
2018-02-09
Accepted
2018-02-09 16:52:05
Documents
7
Period of Report
2018-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d537240d8k.htm 8-K 19855
2 EX-1.1 d537240dex11.htm EX-1.1 178003
3 EX-5.1 d537240dex51.htm EX-5.1 6217
4 EX-99.1 d537240dex991.htm EX-99.1 9075
5 EX-99.2 d537240dex992.htm EX-99.2 9249
6 GRAPHIC g537240ex992.jpg GRAPHIC 4188
7 GRAPHIC g537240ex99_1.jpg GRAPHIC 4251
  Complete submission text file 0001193125-18-038130.txt   235426
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 18592520
SIC: 2834 Pharmaceutical Preparations